Logo image of CBZ

CBIZ INC (CBZ) Stock Fundamental Analysis

NYSE:CBZ - New York Stock Exchange, Inc. - US1248051021 - Common Stock - Currency: USD

72.25  -0.95 (-1.3%)

After market: 72.25 0 (0%)

Fundamental Rating

5

Taking everything into account, CBZ scores 5 out of 10 in our fundamental rating. CBZ was compared to 82 industry peers in the Professional Services industry. CBZ has a medium profitability rating, but doesn't score so well on its financial health evaluation. CBZ is not priced too expensively while it is growing strongly. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CBZ had positive earnings in the past year.
CBZ had a positive operating cash flow in the past year.
In the past 5 years CBZ has always been profitable.
In the past 5 years CBZ always reported a positive cash flow from operatings.
CBZ Yearly Net Income VS EBIT VS OCF VS FCFCBZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.90%, CBZ is in line with its industry, outperforming 46.34% of the companies in the same industry.
CBZ has a Return On Equity (4.54%) which is in line with its industry peers.
The Return On Invested Capital of CBZ (4.10%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for CBZ is significantly below the industry average of 12.27%.
Industry RankSector Rank
ROA 1.9%
ROE 4.54%
ROIC 4.1%
ROA(3y)4.15%
ROA(5y)4.39%
ROE(3y)10.79%
ROE(5y)10.71%
ROIC(3y)6.53%
ROIC(5y)6.32%
CBZ Yearly ROA, ROE, ROICCBZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

CBZ has a Profit Margin (4.03%) which is comparable to the rest of the industry.
CBZ's Profit Margin has declined in the last couple of years.
CBZ has a better Operating Margin (10.37%) than 76.83% of its industry peers.
CBZ's Operating Margin has declined in the last couple of years.
The Gross Margin of CBZ (13.80%) is worse than 81.71% of its industry peers.
In the last couple of years the Gross Margin of CBZ has declined.
Industry RankSector Rank
OM 10.37%
PM (TTM) 4.03%
GM 13.8%
OM growth 3Y-10.26%
OM growth 5Y-4.48%
PM growth 3Y-29.35%
PM growth 5Y-21.21%
GM growth 3Y-10.5%
GM growth 5Y-4.73%
CBZ Yearly Profit, Operating, Gross MarginsCBZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

3

2. Health

2.1 Basic Checks

CBZ has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CBZ has been increased compared to 1 year ago.
Compared to 5 years ago, CBZ has less shares outstanding
CBZ has a worse debt/assets ratio than last year.
CBZ Yearly Shares OutstandingCBZ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CBZ Yearly Total Debt VS Total AssetsCBZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 1.93 indicates that CBZ is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 1.93, CBZ is not doing good in the industry: 62.20% of the companies in the same industry are doing better.
CBZ has a debt to FCF ratio of 17.74. This is a negative value and a sign of low solvency as CBZ would need 17.74 years to pay back of all of its debts.
With a Debt to FCF ratio value of 17.74, CBZ is not doing good in the industry: 65.85% of the companies in the same industry are doing better.
CBZ has a Debt/Equity ratio of 0.76. This is a neutral value indicating CBZ is somewhat dependend on debt financing.
CBZ has a worse Debt to Equity ratio (0.76) than 62.20% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF 17.74
Altman-Z 1.93
ROIC/WACC0.5
WACC8.14%
CBZ Yearly LT Debt VS Equity VS FCFCBZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

CBZ has a Current Ratio of 1.52. This is a normal value and indicates that CBZ is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.52, CBZ is in line with its industry, outperforming 52.44% of the companies in the same industry.
A Quick Ratio of 1.52 indicates that CBZ should not have too much problems paying its short term obligations.
CBZ's Quick ratio of 1.52 is in line compared to the rest of the industry. CBZ outperforms 56.10% of its industry peers.
Industry RankSector Rank
Current Ratio 1.52
Quick Ratio 1.52
CBZ Yearly Current Assets VS Current LiabilitesCBZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

9

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 34.41% over the past year.
Measured over the past years, CBZ shows a quite strong growth in Earnings Per Share. The EPS has been growing by 15.05% on average per year.
CBZ shows a strong growth in Revenue. In the last year, the Revenue has grown by 32.27%.
Measured over the past years, CBZ shows a quite strong growth in Revenue. The Revenue has been growing by 13.84% on average per year.
EPS 1Y (TTM)34.41%
EPS 3Y16%
EPS 5Y15.05%
EPS Q2Q%49.67%
Revenue 1Y (TTM)32.27%
Revenue growth 3Y17.96%
Revenue growth 5Y13.84%
Sales Q2Q%69.54%

3.2 Future

The Earnings Per Share is expected to grow by 26.87% on average over the next years. This is a very strong growth
CBZ is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 30.84% yearly.
EPS Next Y41.11%
EPS Next 2Y26.87%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year61.9%
Revenue Next 2Y30.84%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CBZ Yearly Revenue VS EstimatesCBZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B
CBZ Yearly EPS VS EstimatesCBZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 21.76, the valuation of CBZ can be described as rather expensive.
CBZ's Price/Earnings ratio is in line with the industry average.
CBZ is valuated rather cheaply when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
CBZ is valuated rather expensively with a Price/Forward Earnings ratio of 17.53.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CBZ is on the same level as its industry peers.
CBZ is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 21.76
Fwd PE 17.53
CBZ Price Earnings VS Forward Price EarningsCBZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

CBZ's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CBZ is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 45.61
EV/EBITDA 19.16
CBZ Per share dataCBZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30

4.3 Compensation for Growth

CBZ's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CBZ's earnings are expected to grow with 26.87% in the coming years.
PEG (NY)0.53
PEG (5Y)1.45
EPS Next 2Y26.87%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CBZ!.
Industry RankSector Rank
Dividend Yield N/A

CBIZ INC

NYSE:CBZ (7/11/2025, 8:04:00 PM)

After market: 72.25 0 (0%)

72.25

-0.95 (-1.3%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)04-24 2025-04-24/bmo
Earnings (Next)07-24 2025-07-24/bmo
Inst Owners83.3%
Inst Owner Change0%
Ins Owners3.45%
Ins Owner Change7.67%
Market Cap3.93B
Analysts85.71
Price Target96.9 (34.12%)
Short Float %5.18%
Short Ratio5.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.56%
Min EPS beat(2)7.63%
Max EPS beat(2)17.49%
EPS beat(4)3
Avg EPS beat(4)-2.12%
Min EPS beat(4)-43.49%
Max EPS beat(4)17.49%
EPS beat(8)6
Avg EPS beat(8)-1.43%
EPS beat(12)9
Avg EPS beat(12)2.47%
EPS beat(16)12
Avg EPS beat(16)1.07%
Revenue beat(2)1
Avg Revenue beat(2)4.27%
Min Revenue beat(2)-3.55%
Max Revenue beat(2)12.08%
Revenue beat(4)1
Avg Revenue beat(4)1.3%
Min Revenue beat(4)-3.55%
Max Revenue beat(4)12.08%
Revenue beat(8)4
Avg Revenue beat(8)1.65%
Revenue beat(12)8
Avg Revenue beat(12)3.22%
Revenue beat(16)12
Avg Revenue beat(16)3.91%
PT rev (1m)0%
PT rev (3m)-3.55%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-13.06%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.11%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.44%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.47%
Valuation
Industry RankSector Rank
PE 21.76
Fwd PE 17.53
P/S 1.82
P/FCF 45.61
P/OCF 39.64
P/B 2.05
P/tB N/A
EV/EBITDA 19.16
EPS(TTM)3.32
EY4.6%
EPS(NY)4.12
Fwd EY5.7%
FCF(TTM)1.58
FCFY2.19%
OCF(TTM)1.82
OCFY2.52%
SpS39.65
BVpS35.2
TBVpS-18.23
PEG (NY)0.53
PEG (5Y)1.45
Profitability
Industry RankSector Rank
ROA 1.9%
ROE 4.54%
ROCE 5.7%
ROIC 4.1%
ROICexc 4.11%
ROICexgc 15.92%
OM 10.37%
PM (TTM) 4.03%
GM 13.8%
FCFM 3.99%
ROA(3y)4.15%
ROA(5y)4.39%
ROE(3y)10.79%
ROE(5y)10.71%
ROIC(3y)6.53%
ROIC(5y)6.32%
ROICexc(3y)6.56%
ROICexc(5y)6.34%
ROICexgc(3y)21.85%
ROICexgc(5y)20.77%
ROCE(3y)9.09%
ROCE(5y)8.79%
ROICexcg growth 3Y-18.93%
ROICexcg growth 5Y-6.45%
ROICexc growth 3Y-27.55%
ROICexc growth 5Y-15.96%
OM growth 3Y-10.26%
OM growth 5Y-4.48%
PM growth 3Y-29.35%
PM growth 5Y-21.21%
GM growth 3Y-10.5%
GM growth 5Y-4.73%
F-Score3
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF 17.74
Debt/EBITDA 5.09
Cap/Depr 20.46%
Cap/Sales 0.6%
Interest Coverage 250
Cash Conversion 34.53%
Profit Quality 99.14%
Current Ratio 1.52
Quick Ratio 1.52
Altman-Z 1.93
F-Score3
WACC8.14%
ROIC/WACC0.5
Cap/Depr(3y)38.86%
Cap/Depr(5y)40%
Cap/Sales(3y)0.92%
Cap/Sales(5y)0.96%
Profit Quality(3y)163.09%
Profit Quality(5y)166.86%
High Growth Momentum
Growth
EPS 1Y (TTM)34.41%
EPS 3Y16%
EPS 5Y15.05%
EPS Q2Q%49.67%
EPS Next Y41.11%
EPS Next 2Y26.87%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)32.27%
Revenue growth 3Y17.96%
Revenue growth 5Y13.84%
Sales Q2Q%69.54%
Revenue Next Year61.9%
Revenue Next 2Y30.84%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y32.52%
EBIT growth 3Y5.86%
EBIT growth 5Y8.74%
EBIT Next Year153.94%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-28.84%
FCF growth 3Y-3.22%
FCF growth 5Y5.61%
OCF growth 1Y-25.18%
OCF growth 3Y-1.95%
OCF growth 5Y4.72%